Hangzhou Tigermed Consulting Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong

Every trade that managers of Hangzhou Tigermed Consulting Co., Ltd. - H Shares disclose to HKEX is tracked on this page. The company sits in the Health Care sector. 3 insiders have disclosed 4 filings since 22 October 2025.

Only purchases show up on the open market, 2 purchases in all, filed by 2 insiders. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 2 senior executives.

The last purchase on record was published on 15 October 2026, which is 24 days ago. Filings reach the HKEX feed a median of 6 days after the trade. That lag is the time during which only the insider knows about the trade.

Compared with its exchange (1,314 companies, median 4 filings), a count of 4 filings is typical. Over the whole record (from 2026), the tally stands at 2 purchases and no sales.

For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.